Paper-Based procalcitonin and Interleukin-6 test strip with Spectrum-Based optical reader for enterovirus severity

Cheng-Han Chen1, Rui-Ling Huang2, Ching-Chuan Liu3

  • 1Department of Emergency Medicine, Taipei Veterans General Hospital, Taipei 11217, Taiwan; School of Medicine, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan.

Insights

A new point-of-care test (POCT) system measures PCT and IL-6 rapidly. Interleukin-6 (IL-6) effectively identified severe neurological complications in enterovirus infections.

Area of Science:

  • Infectious Diseases
  • Clinical Diagnostics
  • Biomarker Analysis

Background:

  • Infectious diseases pose global health risks, requiring rapid diagnosis to prevent sepsis.
  • Early identification of neurological complications in enterovirus infections is difficult due to non-specific symptoms.
  • Point-of-care testing (POCT) offers a promising solution for rapid diagnostics, particularly low-cost lateral-flow assays.

Purpose of the Study:

  • To develop and evaluate a novel point-of-care diagnostic system for simultaneous measurement of Procalcitonin (PCT) and Interleukin-6 (IL-6).
  • To assess the system's efficacy in differentiating severe pediatric enterovirus cases and identifying neurological complications.
  • To explore the potential of this diagnostic platform in resource-limited settings for early sepsis recognition and infectious disease management.

Main Methods:

  • Development of a PCT/IL-6 rapid diagnostic system combining lateral flow assay (LFA) test strips with a portable optical spectrum reader.
  • Simultaneous semi-quantitative measurement of serum PCT and IL-6 within 30 minutes at the point of care.
  • Validation of the system against traditional Enzyme-Linked Immunosorbent Assay (ELISA) using patient serum samples.

Main Results:

  • The developed system showed a strong correlation with established ELISA methods.
  • The PCT/IL-6 system successfully differentiated severe pediatric enterovirus cases.
  • Interleukin-6 (IL-6) demonstrated superior ability compared to Procalcitonin (PCT) in identifying patients with severe neurological complications.

Conclusions:

  • The novel PCT/IL-6 rapid diagnostic platform enables timely point-of-care measurement of key biomarkers.
  • This system is effective in diagnosing severe enterovirus infections and predicting neurological complications.
  • The technology holds significant potential for improving sepsis recognition and infectious disease management, especially in resource-limited environments.